Medtronic, Inc. (MDT) Warns on Wire Damage Risk With Deep-Brain Stimulation Implants
5/3/2013 8:51:17 AM
Staying up-to-date has never been simpler. Sign up for the free
GenePool newsletter today!
Medtronic (NYSE:MDT) warned physicians of the potential for the wires used with its deep-brain stimulation implants to be damaged during implantation, prompting the FDA to label Medtronic's "Urgent Medical Device Correction" as a Class I recall – denoting a device with the potential to cause severe injury or death. Fridley, Minn.-based Medtronic said its February 2013 warning concerned the lead cap and a connector used during the implantation procedure of the DBS devices, which are used to treat Parkinson's disease and other disorders.
Help employers find you! Check out all the jobs and post your resume.